Problem with product information in dosage instructions

Problem with product information in dosage instructions

Prescribers shouldn’t include product info so that it appears within the dosage instructions area  and a paper prescription might be required on occasion.

See also: Problem with EPS product info in dose instruction area factsheet (pdf one-pager PSNC factsheet).

Background: Prescribers shouldn’t include product info within the dosage instructions

Occasionally, for EPS or paper prescriptions, prescribers include supplementary product information, for example: an indication of unlicensed, a brand/manufacturer or sugar/preservative-free prescription within patient dosage instructions rather than as part of the name of the prescribed product (e.g. image further below).

Product information in an incorrect place

There is the risk that it will be missed by the patient/pharmacy. Furthermore with paper prescriptions it can easily be missed. With electronic prescriptions, pricing will be based on the product code of the prescribed product, therefore, supplementary product information included in the prescriber’s dosage instructions will not be considered when calculating payment.

Requesting prescription is re-issued

If prescriptions are received with supplementary product information in the dosage instructions, the prescriber should be contacted so that the item can be cancelled and a new prescription generated can be issued with the item described correctly (product information in main-name entry). There will be occasions where a prescriber cannot issue the prescription they wish via EPS for technical reasons. For example, this could occur if the product is not listed within the NHS medicinal item list (Dictionary of Medicines & Devices, dm+d) or if the prescribing system is not able to issue a prescription for the item because the supplier has not ‘mapped’ the appropriate codes. This is likely to affect less commonly prescribed items including products  unlicensed items.

FAQs

Q. I have received a prescription and see that supplementary product information (e.g. ‘assorted flavours’ or ‘unlicensed’) is included within the dose instructions area. Will the prescription be priced correctly and is this prescription valid?

There is the risk that the product information within the dosage area will be missed by the patient/pharmacy and NHSBSA: With paper prescriptions it can easily be missed. With electronic prescriptions, pricing will be based on the product code of the prescribed product, therefore, supplementary product information included in the prescriber’s dosage instructions will not be considered when calculating payment. Some prescriptions will need to be re-issued as paper prescriptions. See further information on this webpage.

 

Further info

Read more at:

If you have queries on this webpage or you require more information please contact it@psnc.org.uk. Note: Community pharmacy teams can see what items are listed within dm+d: psnc.org.uk/dmd includes links to dm+d viewers such as the NHSBSA dm+d viewer and OpenPrescribing dm+d viewer. To share and hear views about digital developments with like-minded pharmacy team members, join the CP Digital email group today.

 

 

Return to the IT section: EPS home / eRD / Smartcards / System suppliers

Return to the EPS sections relating to: Overview / Preparing&enhancing EPS / Nomination / Dispensing&Supply EPS / CDs  / Tokens / EPS/IT contingency planning / Submission / Cancelling/changing EPS / RTEC / Future

EPS resources/factsheets also include: EPS essential checklistsEPS CDs FAQschecking EPS totalsNomination PrinciplesEPS/IT/ODS changePhase 4Reporting EPS issuesEPS studies including tips and lessonsSubmitting EPS in timeTokensTrackerUpgrading EPS from Release 1 to 2

Ask a question about pharmacy IT: it@psnc.org.uk

Return to the Pharmacy IT hub



Latest Dispensing and Supply news

View more Dispensing and Supply news >